Lyonia ovalifolia var. hebecarpa
Lyonia ovalifolia var. hebecarpa · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Lyonia ovalifolia var. hebecarpa is a distinctive botanical species known for its unique physiological characteristics. Research has increasingly focused on the medicinal potential found within its biological structure. Specifically, the leaves of this plant have demonstrated significant antiproliferative activities in various studies. This biological property suggests that the plant may play a role in inhibiting the growth of certain cells. Understanding these leaf-derived compounds provides valuable insights into the plant's therapeutic applications.
- Synonyms
- Pieris Henryi · Pieris Mairei · 3 more
- Common names
- Not available
- Family
- Ericaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Lyonia ovalifolia var. hebecarpa is a distinctive plant recognized by several different local names. It is widely known by its common name 南烛, reflecting its place in regional botanical culture. Additionally, many enthusiasts and researchers refer to this specific variety as 毛果珍珠花. These overlapping names highlight the diverse ways the species is identified within its natural habitat. Understanding these various aliases is essential for anyone studying the unique characteristics of this beautiful shrub.
Sources: Catalogue of Life (COL)
Synonyms
Lyonia ovalifolia var. hebecarpa is a botanical subject characterized by a complex history of taxonomic classifications. Throughout various studies, this variety has been identified under several different scientific names, including the synonyms Pieris henryi and Pieris mairei. Its nomenclature further extends to include Pieris mairei var. parvifolia and the closely related Pieris ovalifolia var. hebecarpa. Researchers have also documented its relationship to the genus Xolisma through the synonym Xolisma ovalifolia var. hebecarpa. Understanding these shifting botanical designations is essential for accurately identifying the plant across different scientific literatures.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Lyonia ovalifolia var. hebecarpa is a distinctive botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, it is classified under the class Equisetopsida and the order Ericales. This specific plant is a member of the Ericaceae family, which highlights its unique biological characteristics. It is further identified by its placement within the genus Lyonia. Understanding these taxonomic relationships provides essential insight into the evolutionary history of this variety.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Ericaceae |
| Genus | Lyonia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lyonia ovalifolia var. hebecarpa is a botanical variety primarily found within the Asia-Temperate region. Its natural range is concentrated within China, spanning several distinct geographical areas. Specifically, this plant can be located across the North-Central provinces of the country. Furthermore, its distribution extends into the South-Central territories of China. The variety also thrives within the Southeast regions, completing its broad presence across the nation.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Lyonia ovalifolia var. hebecarpa has been identified as a significant source of bioactive compounds, specifically eleven newly discovered lanostane-type triterpene glycosides known as hebecarposides A-K. These specialized metabolites, isolated from the plant's leaves, demonstrate notable antiproliferative activity against several different cancer cell lines. Specifically, hebecarposides C, D, G, and K were found to selectively inhibit the proliferation of HL-60 and SMMC-7721 cells. Remarkably, certain compounds like hebecarposides C and D outperformed the standard control, cis-platin, in suppressing A-549 cell lines. Furthermore, hebecarposides C and H exhibited even more potent anti-proliferative effects against MCF-7 cells than the positive control, highlighting the therapeutic potential of this variety.
Compounds
Conditions
Lyonia ovalifolia var. hebecarpa contains lanostane-type triterpene glycosides that exhibit antiproliferative activity against several cancer cell lines. Specifically, the plant's compounds demonstrate the ability to treat the A-549 cell line, with certain hebecarposides even outperforming cis-platin. The plant also shows effectiveness against the HL-60 and SMMC-7721 cell lines through the selective inhibition of cell proliferation. Furthermore, the extracts provide treatment for MCF-7 cells, where specific compounds exhibit more potent anti-proliferative activities than the positive control. Finally, the medicinal properties of the plant extend to the treatment of the SW480 cell line.
Preparations
Parts used
Lyonia ovalifolia var. hebecarpa serves as a significant source of bioactive compounds located specifically within its leaves. Recent chemical investigations have led to the isolation of eleven previously undescribed lanostane-type triterpene glycosides, known as hebecarposides A-K. These unique leaf-derived constituents were identified through extensive spectroscopic analysis and structural determination. Beyond their chemical novelty, these glycosides demonstrate promising antiproliferative activities against several specific cancer cell lines. Notably, certain compounds from the leaves showed even greater effectiveness against certain cells than the standard treatment, cis-platin.